BerGenBio's Series B - II Round

BerGenBio raised a round of funding on February 05, 2014.

BerGenBio is an oncology-based biopharmaceutical company focused on pursuing therapeutic treatments for cancer and supporting the screening and identification of a wide array of potential targets in c…

Articles about BerGenBio's Series B - II Round: